简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Video
Research
HOME
·
07522.HK
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product (07522.HK) Falls 1.52% in Afternoon Trade, AUM at HKD 217 Million
Tags:
07522.HK
ETF
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product
2026-08-27
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product (07522.HK) Rises 2.32% in Intraday Trade, Volume at 1.1512 Million Shares
Tags:
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product
07522.HK
ETF
2026-08-19
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product (07522.HK) Rises 2.57%, Latest Price at HKD 3.510 in Morning Trade
Tags:
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product
07522.HK
ETF
2026-08-18
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product (07522.HK) Falls 1.98% in Afternoon Trade, Turnover Reaches HKD 1.6169 Million
Tags:
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product
ETF
07522.HK
2026-08-14
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product (07522.HK) Falls 3.41% in Afternoon Trade, Turnover Reaches HKD 2.9277 Million
Tags:
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product
07522.HK
ETF
2026-08-04
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product (07522.HK) Falls 7.83% in Afternoon Trade, Turnover Reaches HKD 2.6443 Million
Tags:
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product
07522.HK
ETF
2026-07-31
ChinaAMC NASDAQ-100 Index Daily (2x) Leveraged Product (07261.HK) Falls 2.85% in Afternoon Trade, AUM at HKD 63.8972 Million
Tags:
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product
07522.HK
ETF
2026-07-30
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product (07522.HK) Rises 5.66% in Intraday Trade, Latest Price at HKD 4.070
Tags:
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product
07522.HK
ETF
2026-07-28
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product (07522.HK) Rises 2.70% in Intraday Trade, Latest NAV at HKD 3.872
Tags:
07522.HK
ETF
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product
2026-07-24
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product (07522.HK) Rose 4.01% in Morning Trade, Turnover at HKD 1.8361 Million
Tags:
07522.HK
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product
ETF
2026-07-17
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product (07522.HK) Falls 1.62% in Afternoon Trade, AUM at HKD 191.00 Million
Tags:
07522.HK
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product
ETF
2026-07-09
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product (07522.HK) Rises 5.85% in Afternoon Trade, Latest NAV at HKD 3.637
Tags:
ETF
07522.HK
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product
2026-06-26
ChinaAMC NASDAQ-100 Index Daily (2x) Leveraged Product (07522.HK) Rises 1.28% in Morning Trade, Volume Ratio at 4.40
Tags:
ChinaAMC NASDAQ-100 Index Daily (2x) Leveraged Product
07522.HK
ETF
2026-06-24
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product(07522.HK) Rises 1.58% Intraday at an Average Price of HK$3.872
Tags:
ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product
07522.HK
ETF
2026-06-11
ChinaAMC NASDAQ-100 Index Daily (2x) Leveraged Product (07522.HK) Rises 1.53% Intraday, AUM at Approximately HKD 196 Million
Tags:
ETF
ChinaAMC NASDAQ-100 Index Daily (2x) Leveraged Product
07522.HK
2026-06-11
ChinaAMC NASDAQ-100 Index Daily (2x) Leveraged Product (07522.HK) Rose 1.82% Intraday, with AUM of HKD 185 Million
Tags:
ETF
ChinaAMC NASDAQ-100 Index Daily (2x) Leveraged Product
07522.HK
2026-06-10
ChinaAMC NASDAQ-100 Index Daily (2x) Leveraged Product (07522.HK) Surges Nearly 6% Intraday, NAV Approximately HKD 3.789
Tags:
ETF
ChinaAMC NASDAQ-100 Index Daily (2x) Leveraged Product
07522.HK
2026-06-08
Featured News
Finance
HBM HOLDINGS-B (02142.HK): Shares Added to Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect Lists, Effective 7 September 2026
Finance
TENNOR THERAP-B (06872.HK): Positive Phase IIa Proof-of-Concept Data for Rifaquizalone (TNP-2092) in Prosthetic Joint Infection; Multicenter Phase IIb Initiated
Finance
CSTONE PHARMA-B (02616.HK): Shares Added to Stock Connect Eligible List, Effective 7 September 2026
Finance
FOSUN PHARMA (02196.HK): Sells 6% Stake in India's Gland Pharma for Approximate USD 294 Million
Finance
PICC GROUP (01339.HK): Nominates Ms. Yang Dongning as Candidate for Executive Director of the Fifth Session of the Board
Finance
KEYMED BIO-B (02162.HK): Non-Executive Director Dr. Wang Minchuan Resigns, Effective 4 September 2026
Finance
KINTOR PHARMA-B (09939.HK): Long-Term Safety Trial of KT-939 Completed; No Skin Adverse Reactions in 114 Subjects Over 52 Weeks
Finance
RIVERINE CHINA (01417.HK): Public Float Falls to 23.85%, Below the 25% Minimum; Restoration Expected Within 6 Months
Finance
CLOVER BIO-B (02197.HK): Positive Phase II Data for Respiratory Combo Vaccine Candidates in Australian Elderly
Finance
WANGUO GOLD GP (03939.HK): Subscribes USD 103.8 Million to JPMorgan Mansart Overnight Fund
Scan QR Code
Download App